TRICYCLIC QUINOLINONE AND TRICYCLIC QUINOLINE AS ANDROGEN RECEPTOR MODULATOR COMPOUNDS

Details for Australian Patent Application No. 2002236115 (hide)

Owner LIGAND PHARMACEUTICALS INCORPORATED

Inventors HIGUCHI, Robert, I.; ZHI, Lin; KARANEWSKY, Donald, S.; THOMPSON, Anthony, W.; CAFERRO, Thomas, R.; MANI, Neelakandha, S.; CHEN, Jyun-Hung; CUMMINGS, Marquis, L.; EDWARDS, James, P.; ADAMS, Mark, E.; DECKHUT, Charlotte, L., F.

Pub. Number AU-A-2002236115

PCT Pub. Number WO2002/068427

Priority 60/271,115 23.02.01 US

Filing date 23 February 2002

Wipo publication date 12 September 2002

International Classifications

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/5365 - ortho- or peri-condensed with heterocyclic ring systems

A61P 005/00 Drugs for disorders of the endocrine system

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002236115

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236116-METHOD TO TREAT SOAPY WASTEWATER

2002236114-TRICYCLIC ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS